Date post: | 14-Apr-2018 |
Category: |
Documents |
Upload: | world-health-advocacy |
View: | 216 times |
Download: | 0 times |
of 16
7/29/2019 Addressing the Social and Economic Burden of Disease in Turkey 2012-2013
1/16
Addressing theSocial and
Economic Burdenof Disease in Turkey
2012-2013
Summary Report of a Multi-Sector Outreach Project
7/29/2019 Addressing the Social and Economic Burden of Disease in Turkey 2012-2013
2/16
Key Project Elements
Stakeholders: Identify health-focused civil societyorganizations patient & business
Analytics: Research paper on the burden of chronicdisease in Turkey by respected Turkish and Internationalacademic experts
Public Policy: Engage the Turkish Ministry of Health (healthPromotion and Prevention Branch)
7/29/2019 Addressing the Social and Economic Burden of Disease in Turkey 2012-2013
3/16
Stakeholder Mapping in Turkey
Objective:
to identify stakeholders with an interest in social andeconomic burden of chronic disease
Results:
79 organizations - including patients rights groups,foundations, economists and academics and health careprovider groups with mandate related to access to
healthcare
61 groups and individuals were selected for follow-upquestionnaires and interviews
7/29/2019 Addressing the Social and Economic Burden of Disease in Turkey 2012-2013
4/16
Stakeholder Audit
Interviews determined:
The therapeutic area of interest A key contact and leadership Corporate structure and governance Source of funding Visibility and/or level of activity Purpose, objective and primary activities
7/29/2019 Addressing the Social and Economic Burden of Disease in Turkey 2012-2013
5/16
Stakeholder Engagement
Result
40-45 organizations invited to a workshop in Oct. 2012 todiscuss burden of chronic disease in Turkey.
Workshop participants: Health Development Directorate of the Turkish Ministry of
Health, Prof Mehtap Tatar Haceteppe University and study co-author, patient advocacy leader from civil society
organization in India, a representative of the Partnership toFight Chronic Disease, a U.S.-based NGO.
A follow up workshop Sept. 2013 in Istanbul
7/29/2019 Addressing the Social and Economic Burden of Disease in Turkey 2012-2013
6/16
Analytics: Transforming Health In Turkey
Co-authors
Professor David Taylor and Dr. Sarah Carter , UCL School ofPharmacy
Professor Dr. Mehtap Tatar, Hacettepe University Dr. Panos Kanavos and Dr. Federico Grimaccia and Dr.
David Tordrup, LSE Health
Paper was shared with key officials from Turkeys Ministry ofHealth prior to release
Turkey MoH participated in release of the paper at a pressconference in Ankara
Transforming Health in Turkey: 21st Century Opportunitieshttp://www.fightchronicdisease.org/media-center/resources/transforming-health-turkey-21st-century-opportunities
7/29/2019 Addressing the Social and Economic Burden of Disease in Turkey 2012-2013
7/16
Key Points Identified
Our report places recent health advances in Turkey incontext of global health improvement in the 20th century
Recognizes opportunities for further improvement in the21st century.
Meant to share information, promote mutualunderstanding, not to impose external agenda on Turkishpolicy makers.
Transforming Health in Turkey: 21st Century Opportunitieshttp://www.fightchronicdisease.org/media-center/resources/transforming-health-turkey-21st-century-opportunities
7/29/2019 Addressing the Social and Economic Burden of Disease in Turkey 2012-2013
8/16
Key Points
Health Improvement in Turkey
Since 1970 life expectancy at birth has risen by 25 yearsand the infant death rate has fallen from about 150 tounder 10 per 1000 live births
However, rising rates of non-communicable disease andLTD causing welfare losses that cost more than currentspending all all forms of health care
Type 2 diabetes has doubled in little more than adecade, above the rate recorded in the US
High vascular disease burdens, relatively high incidenceof COPD and similar conditions
Transforming Health in Turkey: 21st Century Opportunitieshttp://www.fightchronicdisease.org/media-center/resources/transforming-health-turkey-21st-century-opportunities
7/29/2019 Addressing the Social and Economic Burden of Disease in Turkey 2012-2013
9/16
NCDs Cost Turkey in Excess of US $80b
6.5 million DALYs a year (disability adjusted life years)
7/29/2019 Addressing the Social and Economic Burden of Disease in Turkey 2012-2013
10/16
The Importance of Positive Active
Ageing
Policy makers across the world can help to facilitatepositive active ageing through progressive public policy
Prevention and treatment of chronic disease improveshealth at every stage in life, reduces the costs, andopens the way to increased economic productivity
Turkey will benefit more from a healthy and active olderpopulation than a young population with sub-optimal
treatment of long term illness
Transforming Health in Turkey: 21st Century Opportunitieshttp://www.fightchronicdisease.org/media-center/resources/transforming-health-turkey-21st-century-opportunities
7/29/2019 Addressing the Social and Economic Burden of Disease in Turkey 2012-2013
11/16
Economic Losses could be Reduced
if Risk Factors were Eliminated
7/29/2019 Addressing the Social and Economic Burden of Disease in Turkey 2012-2013
12/16
Public Health, National Wealth and
the Role of Pharmaceutical Care
Continue to support economic growth by: Minimizing maternal mortality Promoting the rational use of medicines, smoking cessation,
and exercise amongst both men and women
Use medicines to reduce blood pressure/ cholesterol andto prevent disabilities caused by diabetes or asthma toincrease value in social circumstances
As people age and transition socially they demandenhanced health/social services, and treatments for laterlife conditions such as cancers
Transforming Health in Turkey: 21st Century Opportunitieshttp://www.fightchronicdisease.org/media-center/resources/transforming-health-turkey-21st-century-opportunities
7/29/2019 Addressing the Social and Economic Burden of Disease in Turkey 2012-2013
13/16
Rational Use of Rx
7/29/2019 Addressing the Social and Economic Burden of Disease in Turkey 2012-2013
14/16
Turkeys Opportunities
Increase health investment from the current level of 6 percent of GDP to the OECD average of 9 per cent
Increase the use of pharmaceuticals as a cost effectivehealth care option
Increase the number of primary care professionals Promote innovative pharmacy based services
Transforming Health in Turkey: 21st Century Opportunitieshttp://www.fightchronicdisease.org/media-center/resources/transforming-health-turkey-21st-century-opportunities
7/29/2019 Addressing the Social and Economic Burden of Disease in Turkey 2012-2013
15/16
Fighting Chronic Disease
Patient-Focused Policies and Practices
Advance sustainable-next generation chronic diseaseprevention, early intervention, and management modelsthroughout the health care system and public health
infrastructure
Promote healthy lifestyles and disease prevention andmanagement in every community
Encourage and reward continuous advances in clinicalpractice and research that improve the quality of care forthose with prevalent and costly chronic diseases
Partnership to Fight Chronic Disease http://www.fightchronicdisease.org/about/
7/29/2019 Addressing the Social and Economic Burden of Disease in Turkey 2012-2013
16/16
Fighting Chronic Disease
Patient-Focused Policies and Practices
Accelerate improvements in the quality and availability ofhealth information technology (HIT) throughout the healthcare system
Reduce health disparities by focusing on barriers to goodhealth
Partnership to Fight Chronic Disease http://www.fightchronicdisease.org/about/